Monoamine uptake and metabolism

Monoamine uptake and metabolism refers to the integrated biological system responsible for the clearance and degradation of biogenic amine neurotransmitters, including serotonin, dopamine, and norepinephrine (StatPearls, 2023). This system is composed of two primary mechanisms: reuptake via high-affinity plasma membrane transporters (such as the serotonin transporter, dopamine transporter, and norepinephrine transporter) and enzymatic breakdown (primarily by monoamine oxidase and catechol-O-methyltransferase) (PubMed, 2021). These processes are essential for terminating synaptic signaling and maintaining neurochemical balance within the central and peripheral nervous systems. Dysregulation of these pathways is a central feature in the pathophysiology of major depressive disorder, anxiety, attention-deficit/hyperactivity disorder (ADHD), and Parkinson's disease. Pharmacological agents targeting this system, such as selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs), work by increasing the residence time and concentration of neurotransmitters in the synaptic cleft to restore normal signaling.

Other names

Monoaminergic systemMonoamine clearance and degradationBiogenic amine metabolismMonoamine transport and catabolism

Inhibition of monoamine reuptake transporters (e.g., SERT, DAT, NET) and/or inhibition of metabolic enzymes (e.g., MAO-A, MAO-B, COMT) to increase synaptic neurotransmitter levels.